APA (7th ed.) Citation

Liu, Y., Bi, J., & Lu, J. (2026). Early treatment switch in cardiac AL amyloidosis: A case of suboptimal response to first-line Dara-CyBorD regimen followed by switch to teclistamab. Leukemia & Lymphoma, 67(7), 1639. https://doi.org/10.1080/10428194.2026.2637859

Chicago Style (17th ed.) Citation

Liu, Yang, Jingyi Bi, and Jin Lu. "Early Treatment Switch in Cardiac AL Amyloidosis: A Case of Suboptimal Response to First-line Dara-CyBorD Regimen Followed by Switch to Teclistamab." Leukemia & Lymphoma 67, no. 7 (2026): 1639. https://doi.org/10.1080/10428194.2026.2637859.

MLA (9th ed.) Citation

Liu, Yang, et al. "Early Treatment Switch in Cardiac AL Amyloidosis: A Case of Suboptimal Response to First-line Dara-CyBorD Regimen Followed by Switch to Teclistamab." Leukemia & Lymphoma, vol. 67, no. 7, 2026, p. 1639, https://doi.org/10.1080/10428194.2026.2637859.